Topic: Bivalent Vaccines

Dr. Jen Ashton reported on CDC data showing the bivalent COVID-19 booster has a 52% efficacy rate against symptomatic infection. The hosts criticize this figure, arguing that it is impossible to prove the booster saves lives without double-blind trials. They mock the presentation of the data and suggest that the pharmaceutical industry will eventually switch their slogan from "safe and effective" to "effective and safe" to maintain public compliance.

Massachusetts has reintroduced vaccine incentives, offering $75 gift cards at public library clinics to encourage bivalent booster uptake. Meanwhile, a health system in Alabama has released an "Adult Vaccine Activity Book" for nursing home residents, featuring word scrambles and coloring pages about immunizations. Critics describe the use of children's puzzles for the elderly as a condescending propaganda tactic.

Martha Stewart has faced criticism for a commercial promoting the bivalent COVID-19 vaccine using a samurai sword metaphor. A personal anecdote from a former neighbor in a New York office building claims Stewart had a distinct "musk" or body odor during their shared elevator rides. The discussion reflects a loss of respect for celebrities who align with pharmaceutical marketing campaigns.

The intelligence term "limited hangout" describes a PR strategy where a small amount of truth is released to obscure a larger scandal. This concept is applied to recent reports of bivalent vaccines causing strokes, suggesting the narrative is used to protect the broader vaccine market. The term's origins are often traced back to the Nixon administration during the Watergate investigation.

Dr. David Agus appeared on CBS Mornings to advocate for the new bivalent COVID-19 boosters, noting that only 15% of eligible Americans have received them. He expressed hope that future vaccines will provide "mucosal immunity" to block viral spread and symptomatology. Critics noted the shift in language from vaccines "preventing" infection to "holding" against serious illness.

White House COVID-19 Response Coordinator Dr. Ashish Jha urged Americans to trust physicians over "random dudes on Twitter" regarding vaccine safety. Jha confirmed the government has purchased 171 million doses of the bivalent vaccine, potentially for use as a primary series pending FDA approval. Observers noted Jha's rapid speaking cadence and apparent nervousness during recent press briefings as Anthony Fauci prepares for retirement.

White House COVID-19 Response Coordinator Dr. Ashish Jha stated that the FDA "pushed" the administration to build new bivalent mRNA vaccines. The phrasing of "building" a vaccine rather than developing it is noted as a shift in medical terminology related to mRNA technology and waning immunity.

White House COVID-19 Response Coordinator Dr. Ashish Jha indicated that Americans should expect annual COVID-19 vaccine updates similar to the flu shot. New bivalent vaccines targeting the BA.5 Omicron sub-variant are expected to be available for everyone over age 12. This shift suggests a "reset" of the definition of being fully vaccinated.

Dr. Anthony Fauci acknowledged that immunity from prior infection or vaccination wanes over time, similar to common cold coronaviruses. He announced plans for a bivalent booster in the fall of 2022, targeting both the BA5 variant and the ancestral strain of COVID-19. Critics argue that the continuous push for boosters ignores the evolution of the virus and the potential for vaccine-induced variants.

Dr. Anthony Fauci has begun using the term "upgrade" to describe future iterations of COVID-19 vaccines designed to combat variants from South Africa and the UK. He mentioned "bivalent vaccines" that would target both the original strain and new mutants. The hosts compare this terminology to software licensing, suggesting a model of perpetual "updates" for the human body.